Leap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?

Insider buying vs selling

Have Leap Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LPTX insiders and whales buy or sell their stock.

LPTX Shareholders

What type of owners hold Leap Therapeutics Inc stock?
Perceptive Advisors LLC33.16%8,476,496$11.87MInsider
Douglas E. Onsi31.33%8,009,655$11.21MInsider
Beigene Ltd28.74%7,348,437$10.29MInsider
Augustine Lawlor22.77%5,821,791$8.15MInsider
Christopher Mirabelli22.77%5,821,791$8.15MInsider
Healthcare Ventures Ix LP16.21%4,144,804$5.80MInsider
James H. Cavanaugh10.24%2,618,406$3.67MInsider
John W. Littlechild10.24%2,618,406$3.67MInsider
Lilly Co Eli5.79%1,479,307$2.07MInsider
Baker Bros Advisors LP4.59%1,172,175$1.64MInstitution

1 of 3

LPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UBX18.45%59.43%Net SellingNet Selling
MIRO24.32%19.76%Net Buying
NLTX46.41%53.59%Net BuyingNet Buying

Leap Therapeutics Stock Ownership FAQ

Who owns Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is owned by 29.94% institutional shareholders, 181.26% Leap Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Leap Therapeutics shareholder, owning 8.48M shares representing 33.16% of the company. Perceptive Advisors LLC's Leap Therapeutics shares are currently valued at $11.70M.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.